NVAX
Novavax Inc
10.60$
+0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1,220.4% | -67.8% | +342.7% | -79.7% | +4.5% | +654.9% | -64.1% | -70.6% | +108.9% | -5.2% | -59.4% | – | |
| – | +50.5% | -67.2% | -5.3% | +31.1% | -39.5% | -61.5% | +0.8% | +51.1% | +17.2% | +21.8% | -53.6% | – | |
| – | – | -68.4% | +719.7% | -93.5% | +116.1% | +1,163.6% | -65.5% | -78.2% | +149.1% | -10.8% | -61.0% | – | |
| – | +55.0% | -43.7% | +15.4% | -18.5% | +19.8% | -14.8% | -12.7% | +26.6% | -24.7% | +29.1% | -26.0% | – | |
| – | +44.5% | -44.1% | +16.7% | -30.2% | +10.7% | -38.6% | -9.3% | -27.4% | +7.8% | -15.7% | -7.3% | – | |
| – | +568.6% | -43.6% | +13.3% | -24.2% | +15.7% | -25.0% | -12.9% | +90.2% | -55.5% | +23.1% | -21.6% | – | |
| – | – | – | – | -183.2% | – | – | -79.5% | -268.5% | – | -173.4% | – | – | |
| – | +44.0% | -0.1% | +0.8% | +2.2% | +79.1% | -24.5% | -3.6% | -0.7% | +6.2% | -15.8% | +16.1% | – | |
| – | – | – | – | -174.3% | – | – | -79.3% | -289.0% | – | -147.5% | – | – | |
| – | – | +34.0% | -2.5% | -146.8% | – | -83.9% | -21.2% | -169.5% | – | +162.0% | +73.7% | – | |
| – | – | – | – | -174.7% | – | – | -79.5% | -290.0% | – | -154.2% | – | – | |
| – | – | – | – | -158.6% | – | – | -77.4% | -258.4% | – | -101.9% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.